Korean J Med.
2000 Apr;58(4):392-401.
The diagnostic value of serum and fecal pancreatic elastase-1 in patients with pancreatic disease
- Affiliations
-
- 1Department of Internal Medicine, Institute of Digestive Disease and Nutrition, Korea University College of Medicine, Seoul, Korea.
Abstract
- BACKGROUND
The aims of this study were to evaluate the diagnostic value of pancreatic elastase-1(PE-1)
in patients with pancreatic diseases and compare the significance of PE-1 with that of pancreatic exocrine
function test by pure pancreatic juice (PPJ) collection.
METHODS
For evaluation of PE-1, seventy nine
patients with pancreatic diseases were examined. For evaluation of exocrine pancreatic function by PPJ,
twenty three patients with Chronic pancreatitis(CP) were examined. PPJ was collected by endoscopic cannulation
of main pancreatic duct under the intravenous bolus injection of secretin (0.25 CU/kg body weight) and
cholecystokinin (CCK, 40 ng/kg body weight).
RESULTS
Pancreatic exocrine functions were significantly
decreased in patients with CP showing moderate and severe ductal changes on pancreatogram. The mean
concentration of fecal PE-1 was significantly decreased in patients with CP and pancreatic cancer,
but not in patients with acute pancreatitis. When we analyzed the PE-1 concentration according
to Cambridge classification, the concentration of fecal PE-1 was significantly decreased only in
patients with moderate and severe CP. With a cut off of 200 ug fecal PE-1/g, the sensitivity of PE-1
was 25%, 60%, and 100%, respectively, for mild, moderate and severe CP, and the specificity was 88.1%.
The mean concentration of serum PE-1 was increased both in patients with acute and chronic pancreatitis,
but there was no difference between both group.
CONCLUSION
Fecal PE-1 is useful for diagnosis of pancreatic
exocrine insufficiency in patients with CP, especially in moderate and severe grade of pancreatic
exocrine insufficiency. The diagnostic value of fecal PE-1 was also similar to secretin-CCK test
in pancreatic exocrine insufficiency.